-- AB InBev, Grontmij, Omega Pharma, Philips, Solvay: Benelux Equity Preview
-- John Martens
-- 2010-06-15T06:32:59Z
-- http://www.bloomberg.com/news/2010-06-15/ab-inbev-grontmij-omega-pharma-philips-solvay-benelux-equity-preview.html

          
          
             The following companies may have
unusual price changes in Benelux markets. Stock symbols are in
parentheses, and prices are from the previous close.  
 The  Amsterdam Exchanges Index  gained 5.89, or 1.8 percent,
to 331.45. Belgium’s  Bel20 Index  added 34.39, or 1.4 percent, to
2,498.24. Luxembourg’s  LuxX Index  rose 2.6 percent to 1,432.41.  
 Dutch stocks:  
 Royal BAM Groep NV  (BAMNB NA): The Dutch builder said it
received subscriptions representing about 92.2 percent of its
rights offering of about 249 million euros ($303 million). BAM
rose 3.4 percent to 4.43 euros.  
 Grontmij NV  (GRONT NA): The Dutch designer of roads and
bridges agreed to by 51.8 percent of the shares of Ginger SA and
will offer to buy all of the outstanding shares for 28.20 euros
apiece. Grontmij rose 0.8 percent to 14.90 euros.  
 Royal Philips Electronics NV  (PHIA NA): Europe’s biggest
maker of consumer electronics was raised to “overweight” from
“equal weight” at Morgan Stanley. Philips climbed 3 percent to
25.79 euros.  
 Belgian stocks:  
 Anheuser-Busch InBev NV  (ABI BB): Patrinvest SCA, a
Luxembourg-based company controlled by Belgium’s Van Damme and
Van der Straten-Ponthoz families, sold 75.2 million euros of
Anheuser-Busch InBev stock, according to a regulatory filing. AB
InBev gained 1.7 percent to 41 euros.  
 Befimmo SCA  (BEFB BB): Belgium’s second-biggest real estate
investment fund, teaming up with property developers Kairos and
Cavens, agreed to buy Vivaqua’s 15,000 square-meter office in
Brussels for 22.3 million euros, De Tijd reported, without
saying where it got the information. Befimmo dropped 0.9 percent
to 57.31 euros.  
 Omega Pharma NV  (OME BB): Capital Research & Management Co.
increased its holding in Belgium’s biggest supplier of pharmacy
products to 5.06 percent of voting rights as of June 11 from
3.13 percent on March 28. Omega Pharma rose 0.3 percent to 37.59
euros.  
 Solvay SA  (SOLB BB): The chemicals and plastics maker that
sold its drug division to Abbott Laboratories said it spent
almost 2.73 million euros buying back an additional 39,065
shares in the three-day period that started June 7. Solvay
increased 2.1 percent to 73.58 euros.  
 To contact the reporter on this story:
 John Martens  in Brussels at 
 jmartens1@bloomberg.net   
          
          


  


        